Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Hypochlorite
2. Hypochlorous Acids
1. 7790-92-3
2. Hocl
3. Hclo
4. Chloranol
5. Epicyn Hydrogel
6. Comfosy
7. Hydroxidochlorine
8. Hypochloric Acid
9. Chebi:24757
10. 712k4cdc10
11. Einecs 232-232-5
12. Hydroxychloride
13. Oxylchloride
14. Chloro-alcohol
15. Oxyl Chloride
16. Unii-712k4cdc10
17. Hydroxy Chloride
18. Chlor(i)-saeure
19. Hypochlorige Saeure
20. [cloh]
21. Chlorine Oxide (clo1-)
22. Hypochlorous Acid Ion(1-)
23. Hypochlorous Acid [mi]
24. Chembl1616046
25. Dtxsid3036737
26. Hypochlorous Acid [inci]
27. Hypochlorous Acid [vandf]
28. Hypochlorous Acid [who-dd]
29. Db14135
30. Ft-0695042
31. Ft-0775244
32. C19697
33. Q407318
34. Q2535800
35. 8tr
| Molecular Weight | 52.46 g/mol |
|---|---|
| Molecular Formula | ClHO |
| XLogP3 | 0.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 51.9715923 g/mol |
| Monoisotopic Mass | 51.9715923 g/mol |
| Topological Polar Surface Area | 20.2 Ų |
| Heavy Atom Count | 2 |
| Formal Charge | 0 |
| Complexity | 2 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Oxidants
Electron-accepting molecules in chemical reactions in which electrons are transferred from one molecule to another (OXIDATION-REDUCTION). (See all compounds classified as Oxidants.)
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
RLF-TD011 is a differentiated hypotonic, acid-oxidizing solution formulated with hypochlorous acid, offering strong antimicrobial and anti-inflammatory properties for epidermolysis bullosa.
Lead Product(s): Hypochlorous Acid,Inapplicable
Therapeutic Area: Rare Diseases and Disorders Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 22, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hypochlorous Acid,Inapplicable
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011
Details : RLF-TD011 is a differentiated hypotonic, acid-oxidizing solution formulated with hypochlorous acid, offering strong antimicrobial and anti-inflammatory properties for epidermolysis bullosa.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 22, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Acuicyn (hypochlorous acid) is an antimicrobial eyelid and eyelash hygiene solution which removes encrustation and debris, to help manage red, inflamed, itchy eyes.
Lead Product(s): Hypochlorous Acid,Inapplicable
Therapeutic Area: Ophthalmology Brand Name: Acuicyn
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 21, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hypochlorous Acid,Inapplicable
Therapeutic Area : Ophthalmology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Sonoma Relaunches Prescription Dermatology and Eye Care Products in the US
Details : Acuicyn (hypochlorous acid) is an antimicrobial eyelid and eyelash hygiene solution which removes encrustation and debris, to help manage red, inflamed, itchy eyes.
Product Name : Acuicyn
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 21, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
RLF-TD011 is a highly pure, stabilized hypochlorous acid solution developed using Relief's proprietary TEHCLO™ technology, being developed for the treatment of epidermolysis bullosa.
Lead Product(s): Hypochlorous Acid,Inapplicable
Therapeutic Area: Rare Diseases and Disorders Brand Name: Nexodyn AOS
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 11, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hypochlorous Acid,Inapplicable
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Relief Reports Positive RLF-TD011 Results for Epidermolysis Bullosa Clinical Trial
Details : RLF-TD011 is a highly pure, stabilized hypochlorous acid solution developed using Relief's proprietary TEHCLO™ technology, being developed for the treatment of epidermolysis bullosa.
Product Name : Nexodyn AOS
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 11, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Nexodyn AOS is a highly pure, stabilized hypochlorous acid solution developed using Relief's proprietary TEHCLO technology. It is being evaluated for the treatment of epidermolysis bullosa.
Lead Product(s): Hypochlorous Acid,Inapplicable
Therapeutic Area: Rare Diseases and Disorders Brand Name: Nexodyn AOS
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable October 08, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hypochlorous Acid,Inapplicable
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Relief Therapeutics Reports Promising Results For RLF-TD011 in EB Trial
Details : Nexodyn AOS is a highly pure, stabilized hypochlorous acid solution developed using Relief's proprietary TEHCLO technology. It is being evaluated for the treatment of epidermolysis bullosa.
Product Name : Nexodyn AOS
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 08, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
The funding will advance company pipeline, including the clinical development of its patent-protected Nexodyn AOS (hypochlorous acid) topical spray, RLF-TD011, for treating epidermolysis bullosa.
Lead Product(s): Hypochlorous Acid,Inapplicable
Therapeutic Area: Rare Diseases and Disorders Brand Name: Nexodyn AOS
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: SWK Holdings Corporation
Deal Size: $11.0 million Upfront Cash: Undisclosed
Deal Type: Financing September 23, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hypochlorous Acid,Inapplicable
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : SWK Holdings Corporation
Deal Size : $11.0 million
Deal Type : Financing
Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement
Details : The funding will advance company pipeline, including the clinical development of its patent-protected Nexodyn AOS (hypochlorous acid) topical spray, RLF-TD011, for treating epidermolysis bullosa.
Product Name : Nexodyn AOS
Product Type : Miscellaneous
Upfront Cash : Undisclosed
September 23, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
The funding will advance company pipeline, including the clinical development of its patent-protected Nexodyn AOS (hypochlorous acid) topical spray, RLF-TD011, for treating epidermolysis bullosa.
Lead Product(s): Hypochlorous Acid,Inapplicable
Therapeutic Area: Rare Diseases and Disorders Brand Name: Nexodyn AOS
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: SWK Holdings Corporation
Deal Size: $11.0 million Upfront Cash: Undisclosed
Deal Type: Financing August 05, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hypochlorous Acid,Inapplicable
Therapeutic Area : Rare Diseases and Disorders
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : SWK Holdings Corporation
Deal Size : $11.0 million
Deal Type : Financing
Relief Therapeutics Secures up to $11 Million from Royalty Sales
Details : The funding will advance company pipeline, including the clinical development of its patent-protected Nexodyn AOS (hypochlorous acid) topical spray, RLF-TD011, for treating epidermolysis bullosa.
Product Name : Nexodyn AOS
Product Type : Miscellaneous
Upfront Cash : Undisclosed
August 05, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Hypochlorous Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Leg Ulcer.
Lead Product(s): Hypochlorous Acid,Acetic Acid
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 02, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hypochlorous Acid,Acetic Acid
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Hypochlorous Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Leg Ulcer.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 02, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Under the terms of the agreement, Daewoong Pharmaceutical will have the exclusive right to market, sell and distribute Primocyn (hypochlorous acid) Skin Solution products, containing Sonoma's Microcyn technology, in South Korea.
Lead Product(s): Hypochlorous Acid,Inapplicable
Therapeutic Area: Dermatology Brand Name: Primocyn
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Daewoong Pharmaceutical
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement January 31, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hypochlorous Acid,Inapplicable
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Daewoong Pharmaceutical
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the terms of the agreement, Daewoong Pharmaceutical will have the exclusive right to market, sell and distribute Primocyn (hypochlorous acid) Skin Solution products, containing Sonoma's Microcyn technology, in South Korea.
Product Name : Primocyn
Product Type : Miscellaneous
Upfront Cash : Undisclosed
January 31, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Regenacyn Plus (Hypochlorous acid), is an anti-allergic, anti-inflammatory and antipruritic most effective scar gel. It has dual action healing process for infection control, improving new and old keloid and hypertrophic scars and accelerating wound healing.
Lead Product(s): Hypochlorous Acid,Inapplicable
Therapeutic Area: Dermatology Brand Name: Regenacyn Plus
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 04, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hypochlorous Acid,Inapplicable
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Regenacyn Plus (Hypochlorous acid), is an anti-allergic, anti-inflammatory and antipruritic most effective scar gel. It has dual action healing process for infection control, improving new and old keloid and hypertrophic scars and accelerating wound heal...
Product Name : Regenacyn Plus
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 04, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Reliefacyn (hypochlorous acid) is antipruritic, anti-inflammatory, and anti-allergic. Reliefacyn alleviates symptoms such as red bumps, itchy, painful and scaly rashes, shallow skin fissures and peeling, and effectively manages symptoms of eczema/atopic dermatitis.
Lead Product(s): Hypochlorous Acid,Inapplicable
Therapeutic Area: Dermatology Brand Name: Reliefacyn
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable October 27, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hypochlorous Acid,Inapplicable
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Reliefacyn (hypochlorous acid) is antipruritic, anti-inflammatory, and anti-allergic. Reliefacyn alleviates symptoms such as red bumps, itchy, painful and scaly rashes, shallow skin fissures and peeling, and effectively manages symptoms of eczema/atopic ...
Product Name : Reliefacyn
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 27, 2022

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : NEUTRALYTE
Dosage Form : SOLUTION
Dosage Strength : 0.0338%/W/W
Packaging :
Approval Date :
Application Number : 2521393
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : ENVIROCLEANSE A
Dosage Form : SOLUTION
Dosage Strength : 0.0338%
Packaging : 1/5/50 GALLONS 8OZ/16OZ/32OZ/64OZ
Approval Date :
Application Number : 2358042
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : TIE SURFACE CLEANER AND DISINFECTANT
Dosage Form : SPRAY
Dosage Strength : 0.017%/W/W
Packaging :
Approval Date :
Application Number : 2534274
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : ENVIRONIZE ANOLYTE
Dosage Form : SOLUTION
Dosage Strength : 0.0338%/W/W
Packaging :
Approval Date :
Application Number : 2410605
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : ULTRA-LYTE
Dosage Form : SPRAY
Dosage Strength : 0.046%
Packaging : 500ML/1000L
Approval Date :
Application Number : 2362546
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : PURE DEFENDER
Dosage Form : SOLUTION
Dosage Strength : 0.046%
Packaging :
Approval Date :
Application Number : 2514338
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : PCS 1000 PLUS OXIDIZING DISINFECTANT CLEANER
Dosage Form : SOLUTION
Dosage Strength : 0.01%/W/W
Packaging :
Approval Date :
Application Number : 2521431
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : SMARTER SOLUTIONS+ SURFACE CLEANER & DISINFECTANT
Dosage Form : SOLUTION
Dosage Strength : 0.017%/W/W
Packaging :
Approval Date :
Application Number : 2534428
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : PUREROX
Dosage Form : SOLUTION
Dosage Strength : 0.025%/W/W
Packaging :
Approval Date :
Application Number : 2522535
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : CLEANSMART SURFACE CLEANER & DISINFECTANT
Dosage Form : SPRAY
Dosage Strength : 0.017%/W/W
Packaging :
Approval Date :
Application Number : 2532034
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Reply
14 Sep 2024
Reply
03 Sep 2024
Reply
09 Jan 2021

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
95
PharmaCompass offers a list of Hypochlorous Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Hypochlorous Acid manufacturer or Hypochlorous Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hypochlorous Acid manufacturer or Hypochlorous Acid supplier.
A Chlorine hydroxide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chlorine hydroxide, including repackagers and relabelers. The FDA regulates Chlorine hydroxide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chlorine hydroxide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Chlorine hydroxide supplier is an individual or a company that provides Chlorine hydroxide active pharmaceutical ingredient (API) or Chlorine hydroxide finished formulations upon request. The Chlorine hydroxide suppliers may include Chlorine hydroxide API manufacturers, exporters, distributors and traders.
Chlorine hydroxide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chlorine hydroxide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Chlorine hydroxide GMP manufacturer or Chlorine hydroxide GMP API supplier for your needs.
A Chlorine hydroxide CoA (Certificate of Analysis) is a formal document that attests to Chlorine hydroxide's compliance with Chlorine hydroxide specifications and serves as a tool for batch-level quality control.
Chlorine hydroxide CoA mostly includes findings from lab analyses of a specific batch. For each Chlorine hydroxide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chlorine hydroxide may be tested according to a variety of international standards, such as European Pharmacopoeia (Chlorine hydroxide EP), Chlorine hydroxide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chlorine hydroxide USP).